Stem cells are the most primitive and undifferentiated cells with the ability to self-renew and differentiate. Under certain circumstances, they can differentiate into cells or tissues with various functions. According to the function, it can be divided into totipotent, pluripotent, multi-potent, and unipotent.
According to the developmental process, it can be classified into embryonic stem cells, which exist in the blastocyst during early embryonic development. It is the initial type of all cells and can differentiate into human organs and tissues. However, based on ethical considerations, the current application is There is still a lot of controversy; adult stem cells (adult stem cells) exist in adult tissues and have a considerable degree of regeneration and differentiation ability, the most common of which are hematopoietic stem cells (HSC) and mesenchymal stem cells ( Mesenchymal stem cells, MSCs).
At this moment, mesenchymal stem cells have great value in clinical treatment because of their abundant sources, multi-functionality, differentiation ability and immune regulation. Based on the data of Clinical Trials 1 in the United States, there are currently more than 600 clinical cases, which are treated with mesenchymal stem cells, and the main diseases include bone damage, degenerative diseases, immune diseases, myasthenia gravis, diabetes, heart-related diseases, etc.
LifeStar is committed to the research and development of mesenchymal stem cells, and collaborated with National Health Research Institutes Taiwan for the purification and development of mesenchymal stem cells, those high-purity stem cells have been purified to comply with regulations. Culture, as a clinical application of regenerative medicine, in order to ensure the safety of products, LifeStar provided a number of cell tests, including cell surface antigen detection, mycoplasma test, endotoxin test, etc.